Exosome
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ==Exosome== | + | ==Exosome== |
| - | + | ||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
This is a default text for your page '''Exosome'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page '''Exosome'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
| Line 10: | Line 9: | ||
'''Autoimmunity''' | '''Autoimmunity''' | ||
| - | The exosome complex is the target of autoantibodies in | + | The exosome complex is the target of autoantibodies, which are known to be found in people that suffer from various autoimmune diseases (especially PM/Scl overlap syndrome). In the autoimune diseases, antibodies are mainly directed against two of the proteins of the complex, called PM/Scl-100 and PM/Scl-75. |
'''Cancer treatment''' | '''Cancer treatment''' | ||
| - | The | + | The Exosome is found to be inhibited by a cancer chemotherapy drug, which called antimetabolite fluorouracil. This drug is one of the most successful drugs for treating solid tumors. |
== Relevance == | == Relevance == | ||
Revision as of 10:59, 21 November 2014
Exosome
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
